Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.4%

2 terminated/withdrawn out of 58 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

4%

1 of 28 completed trials have results

Key Signals

9 recruiting1 with results

Enrollment Performance

Analytics

N/A
37(84.1%)
Phase 2
3(6.8%)
Phase 3
2(4.5%)
Phase 4
1(2.3%)
Phase 1
1(2.3%)
44Total
N/A(37)
Phase 2(3)
Phase 3(2)
Phase 4(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (58)

Showing 20 of 58 trials
NCT07423403Not ApplicableCompleted

A Non-Face-to-Face Physical Activity Promotion Program for University Students

Role: lead

NCT06027671Not ApplicableRecruiting

Structured Peer-delivered ART and Reentry Community Strategy

Role: collaborator

NCT07385534Not ApplicableRecruiting

Effects of Lower Body EMS Training in Postmenopausal Women

Role: lead

NCT07160322Recruiting

Refractory Breathlessness in COPD

Role: lead

NCT04749888Not ApplicableActive Not Recruiting

Impact of the Korea Early Childhood Home-visiting Intervention

Role: collaborator

NCT05008614Not ApplicableCompleted

Comparison of Continuous ESP Versus TEA After Thoracotomy

Role: collaborator

NCT05333328Phase 4Recruiting

OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

Role: collaborator

NCT05756699Active Not Recruiting

Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma

Role: collaborator

NCT06447532Enrolling By Invitation

Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients

Role: collaborator

NCT06751108Active Not Recruiting

Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients

Role: lead

NCT06703697Not ApplicableRecruiting

Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)

Role: lead

NCT06618638Not ApplicableRecruiting

Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment

Role: collaborator

NCT06138769Phase 2Active Not Recruiting

Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma

Role: collaborator

NCT06470581Not ApplicableNot Yet Recruiting

Thoracic Sympathetic Ganglion Block With Botulinum Toxin Type A

Role: lead

NCT05986461Recruiting

Spatially Transcriptomics Reveals Molecular Signatures in CRPS

Role: lead

NCT06130514Not ApplicableNot Yet Recruiting

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block

Role: lead

NCT04490603Not ApplicableRecruiting

The Effect of Virtual Reality Experience on Infusion-related Pain

Role: lead

NCT04876612Not ApplicableRecruiting

Effect of Limaprost in Combination With Transforaminal Epidural Steroid Injection

Role: lead

NCT05727137Not ApplicableCompleted

Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty

Role: collaborator

NCT06295887Not ApplicableNot Yet Recruiting

Educational Efficacy of VR vs. Simulator in Emergency Medical Training

Role: collaborator